BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2018 9:26:11 AM | Browse: 1243 | Download: 1105
 |
Received |
|
2017-09-05 01:38 |
|
Peer-Review Started |
|
2017-09-07 08:57 |
|
To Make the First Decision |
|
2017-09-25 08:08 |
|
Return for Revision |
|
2017-10-09 01:59 |
|
Revised |
|
2017-11-11 20:27 |
|
Second Decision |
|
2017-12-01 00:20 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2017-12-05 05:58 |
|
Articles in Press |
|
2017-12-05 05:58 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2017-12-15 20:20 |
|
Typeset the Manuscript |
|
2017-12-30 05:30 |
|
Publish the Manuscript Online |
|
2018-01-12 09:26 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Clinical Practice Study |
| Article Title |
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase Ⅱ study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zeynep Gural, Sezer Saglam, Serap Yucel, Esra Kaytan-Saglam, Oktar Asoglu, Cetin Ordu, Hediye Acun, Rasul Sharifov, Semen Onder, Ahmet Kizir and Ethem N Oral |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zeynep Gural, MD, Attending Doctor, Department of Radiation Oncology, Acıbadem University Medical Faculty, Halkalı Merkez Mahallesi, Turgut Özal Blv No:16, Istanbul 34303, Türkiye. zeynep.gural@acibadem.com.tr |
| Key Words |
Rectal cancer; Neoadjuvant chemoradiotherapy; Hyperfractionated accelerated radiotherapy |
| Core Tip |
This study includes first Phase II study evaluating neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant infusional 5-fluorouracil (5-FU) chemotherapy in locally advanced rectal cancer (not resectable cancer). This regimen may gives the clinicians to design other neoadjuvant hyperfractionated accelerated radiotherapies. This study has excellent local control but high perioperative complications. To decrease or modify 5-FU dose could give us better local control. |
| Publish Date |
2018-01-12 09:26 |
| Citation |
Gural Z, Saglam S, Yucel S, Kaytan-Saglam E, Asoglu O, Ordu C, Acun H, Sharifov R, Onder S, Kizir A, Oral EN. Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study. World J Gastrointest Oncol 2018; 10(1): 40-47 |
| URL |
http://www.wjgnet.com/1948-5204/full/v10/i1/40.htm |
| DOI |
http://dx.doi.org/10.4251/wjgo.v10.i1.40 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
